(Q36444964)

14 August 2017

1 reference

title

Concomitant suppression of hyperlipidemia and intestinal polyp formation by increasing lipoprotein lipase activity in Apc-deficient mice (English)

1 reference

14 August 2017

1 reference

1 reference

1 reference

3

Keiji Wakabayashi

1 reference

14 August 2017

Michihiro Mutoh

1

1 reference

14 August 2017

Naoko Niho

series ordinal

2

1 reference

14 August 2017

publication date

1 April 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

387

1 reference

14 August 2017

issue

4

1 reference

14 August 2017

page(s)

381-385

1 reference

Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.051

Mechanisms linking diet and colorectal cancer: the possible role of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.051

Lipoprotein lipase activator NO-1886 (ibrolipim) accelerates the mRNA expression of fatty acid oxidation-related enzymes in rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.051

A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.051

Common mutations of the lipoprotein lipase gene and their clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.051

Potential role for peroxisome proliferator activated receptor (PPAR) in preventing colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.051

Dietary fat, cholesterol and colorectal cancer in a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.051

Lipoprotein lipase: structure, function, regulation, and role in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.051

A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.051

Dose-dependent suppression of hyperlipidemia and intestinal polyp formation in Min mice by pioglitazone, a PPAR gamma ligand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.051

Concurrent suppression of hyperlipidemia and intestinal polyp formation by NO-1886, increasing lipoprotein lipase activity in Min mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.051

Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.051

Transforming growth factor-alpha prevents detachment-induced inhibition of c-Src kinase activity, Bcl-XL down-regulation, and apoptosis of intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.051

Inhibition of adipogenesis by Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.051

Activation of human peroxisome proliferator-activated receptor (PPAR) subtypes by pioglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.051

Enzyme-induction dependent bioactivation of troglitazone and troglitazone quinone in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.051

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.051

The novel compound NO-1886 increases lipoprotein lipase activity with resulting elevation of high density lipoprotein cholesterol, and long-term administration inhibits atherogenesis in the coronary arteries of rats with experimental atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.051

21 January 2018

Identifiers

DOI

10.1515/BC.2006.051

1 reference

14 August 2017

1 reference